| An oncolytic virus expressing IL15/IL15Rα combined with off-the-shelf EGFR-CAR NK cells targets glioblastoma R Ma, T Lu, Z Li, KY Teng, AG Mansour, M Yu, L Tian, B Xu, S Ma, ... Cancer research 81 (13), 3635-3648, 2021 | 110 | 2021 |
| An oncolytic herpesvirus expressing E-cadherin improves survival in mouse models of glioblastoma B Xu, R Ma, L Russell, JY Yoo, J Han, H Cui, P Yi, J Zhang, H Nakashima, ... Nature biotechnology 37 (1), 45-54, 2019 | 80 | 2019 |
| ROR1 is a novel prognostic biomarker in patients with lung adenocarcinoma YZ Zheng, R Ma, JK Zhou, CL Guo, YS Wang, ZG Li, LX Liu, Y Peng Scientific Reports 6 (1), 36447, 2016 | 79 | 2016 |
| The emerging field of oncolytic virus-based cancer immunotherapy R Ma, Z Li, EA Chiocca, MA Caligiuri, J Yu Trends in cancer 9 (2), 122-139, 2023 | 77 | 2023 |
| An oncolytic virus expressing a full-length antibody enhances antitumor innate immune response to glioblastoma B Xu, L Tian, J Chen, J Wang, R Ma, W Dong, A Li, J Zhang, ... Nature communications 12 (1), 5908, 2021 | 72 | 2021 |
| ROR1 expression as a biomarker for predicting prognosis in patients with colorectal cancer JK Zhou, YZ Zheng, XS Liu, Q Gou, R Ma, CL Guo, CM Croce, L Liu, ... Oncotarget 8 (20), 32864, 2017 | 55 | 2017 |
| Specific targeting of glioblastoma with an oncolytic virus expressing a cetuximab-CCL5 fusion protein via innate and adaptive immunity L Tian, B Xu, Y Chen, Z Li, J Wang, J Zhang, R Ma, S Cao, W Hu, ... Nature cancer 3 (11), 1318-1335, 2022 | 30 | 2022 |
| ILC1s control leukemia stem cell fate and limit development of AML Z Li, R Ma, S Ma, L Tian, T Lu, J Zhang, BL Mundy-Bosse, B Zhang, ... Nature immunology 23 (5), 718-730, 2022 | 29 | 2022 |
| Off-the-shelf CAR natural killer cells secreting IL-15 target spike in treating COVID-19 T Lu, R Ma, W Dong, KY Teng, DS Kollath, Z Li, J Yi, C Bustillos, S Ma, ... Nature Communications 13 (1), 2576, 2022 | 28 | 2022 |
| Novel ROR1 inhibitor ARI-1 suppresses the development of non-small cell lung cancer X Liu, W Pu, H He, X Fan, Y Zheng, JK Zhou, R Ma, J He, Y Zheng, K Wu, ... Cancer Letters 458, 76-85, 2019 | 28 | 2019 |
| Hijacking TYRO3 from tumor cells via trogocytosis enhances NK-cell effector functions and proliferation T Lu, R Ma, Z Li, AG Mansour, KY Teng, L Chen, J Zhang, T Barr, ... Cancer immunology research 9 (10), 1229-1241, 2021 | 14 | 2021 |
| Therapeutic application of human type 2 innate lymphoid cells via induction of granzyme B-mediated tumor cell death Z Li, R Ma, H Tang, J Guo, Z Shah, J Zhang, N Liu, S Cao, G Marcucci, ... Cell 187 (3), 624-641. e23, 2024 | 4 | 2024 |
| Human ILC1s target leukemia stem cells and control development of AML M Caligiuri, Z Li, R Ma, H Tang, J Zhang, G Marcucci, J Yu Research Square, 2023 | 3 | 2023 |
| Dual roles of a novel oncolytic viral vector-based SARS-CoV-2 vaccine: Preventing COVID-19 and treating tumor progression Y Sun, W Dong, L Tian, Y Rao, C Qin, SA Jaramillo, EW Settles, S Ma, ... bioRxiv, 2021.06. 07.447286, 2021 | 3 | 2021 |
| Abstract LB211: Tumor-reactive and anti-PD-L1 co-stimulated killer cells (TRACK-NK) for immunotherapy of non-small cell lung cancer T Lu, AG Mansour, R Ma, C Bustillos, Z Li, S Ma, Z Li, H Chen, KY Teng, ... Cancer Research 82 (12_Supplement), LB211-LB211, 2022 | 2 | 2022 |
| An oncolytic herpes virus expressing E-cadherin resists NK cell clearance and improves viral spread and glioblastoma virotherapy B Xu, R Ma, L Russell, JY Yoo, J Han, H Cui, P Yi, J Zhang, H Nakashima, ... Nature biotechnology, 2018 | 2 | 2018 |
| Hijacking TYRO3 from tumor cells via trogocytosis enhances NK-cell effector functions and proliferation. Cancer Immunol. Res. 2021; 9: 1229–1241. doi: 10.1158/2326-6066 T Lu, R Ma, Z Li CIR-20-1014.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 2 | |
| Amendments: Publisher Correction: An oncolytic herpesvirus expressing E-cadherin improves survival in mouse models of glioblastoma B Xu, R Ma, L Russell, JY Yoo, J Han, H Cui, P Yi, J Zhang, H Nakashima, ... Nature Biotechnology 37 (1), 102-103, 2019 | 1 | 2019 |
| Correction: Amendments: Publisher Correction: An oncolytic herpesvirus expressing E-cadherin improves survival in mouse models of glioblastoma B Xu, R Ma, L Russell, JY Yoo, J Han, H Cui, P Yi, J Zhang, H Nakashima, ... Nature Biotechnology 37 (1), 102-102, 2019 | 1 | 2019 |
| Preclinical Evaluation of Off-The-Shelf PD-L1+ Human Natural Killer Cells Secreting IL15 to Treat Non–Small Cell Lung Cancer T Lu, R Ma, AG Mansour, C Bustillos, Z Li, Z Li, S Ma, KY Teng, H Chen, ... Cancer Immunology Research 12 (6), 731-743, 2024 | | 2024 |
